Gebra Cuyún-Carter

14PUBLICATIONS
49CO-AUTHORS
Cancer geneticsPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Query processing and optimisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 19, 2026
Clinical and economic benefits of combined genetic and genomic testing strategies to guide treatment decisions for patients with HR+/HER2- breast cancer in the US.

M Gouldson, Q Le, S Millen

|Feb 15, 2026
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan.

Kei Koizumi, Ataru Igarashi, Mark Gouldson

|Nov 26, 2025
Assigning cancer stage to patients using administrative claims data: an example for colon and rectal cancers.

Rebecca A Smith, Xiting Cao, Gebra Cuyun Carter

|Jun 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

|Jun 10, 2024
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective.

Vladislav Berdunov, Gebra Cuyun Carter, Ewan Laws

|Mar 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patients.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

Pageof 3

Frequent Collaborators

3 joint publications

Mark Gouldson

3 joint publications

David W Hall

3 joint publications

Steve Millen

3 joint publications

Sebastien Eymere